<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05628844</url>
  </required_header>
  <id_info>
    <org_study_id>2022-04200-01</org_study_id>
    <nct_id>NCT05628844</nct_id>
  </id_info>
  <brief_title>Nutrient Uptake During Continuous Enteral Feeding</brief_title>
  <official_title>Uptake of Glucose and Phenylalanine From Continuous Enteral Nutrition in Healthy and Critically Ill Persons</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Felix Liebau</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Karolinska University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Karolinska Institutet</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Region Stockholm</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous enteral nutrition is used to feed patients in intensive care who are unable to eat&#xD;
      normally. The goal of this observational study is to learn about the uptake of nutrients from&#xD;
      feeding formula. The study method will first be applied in healthy persons to establish&#xD;
      workability and normal values, then in patients in the intensive care unit to learn how&#xD;
      nutrient uptake is affected by critical illness.&#xD;
&#xD;
      The main questions this study aims to answer are:&#xD;
&#xD;
        -  what is the time course of uptake of phenylalanine (an amino acid) and glucose (a sugar)&#xD;
           from enteral feeding formula given continuously over several hours&#xD;
&#xD;
        -  what is the time course of the filling volume of the stomach during continuous enteral&#xD;
           feeding&#xD;
&#xD;
      Participants receive feeding formula through a nasogastric feeding tube and blood samples are&#xD;
      taken at short intervals to analyse uptake of nutrients into blood. Simultaneously, the&#xD;
      filling volume of the stomach is measured by gastric ultrasound.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background&#xD;
&#xD;
      The investigators have previously studied the uptake of dietary isotope-labeled phenylalanine&#xD;
      and plasma amino acid concentrations in critically ill patients and healthy subjects. During&#xD;
      continuous feeding, uptake was unexpectedly found to be highly variable over time. Due to&#xD;
      infrequent sampling, the time course of variability could not be modeled mathematically.&#xD;
      Also, the underlying physiological mechanisms remain unclear, though it is hypothesized that&#xD;
      gastric emptying is a major factor determining temporal variability.&#xD;
&#xD;
      The study here described is a follow-up that includes serial abdominal ultrasound studies to&#xD;
      measure gastric emptying, additional indicators/tracers to determine more detail of uptake&#xD;
      vs. digestion/transport/metabolism, and makes use of more frequent sampling to allow for&#xD;
      detailed mathematical modeling of temporal variability.&#xD;
&#xD;
      Experimental protocol&#xD;
&#xD;
      ICU patients:&#xD;
&#xD;
        -  Standard care and treatment as per clinical routines&#xD;
&#xD;
        -  Pre-experiment ongoing nutrition for ≥ 6 hrs by nasogastric feeding tube or gastrostomy&#xD;
           (not postpyloric)&#xD;
&#xD;
        -  Bed rest during experiment as feasible&#xD;
&#xD;
      Healthy subjects&#xD;
&#xD;
        -  Keep dietary and training habits for ≥ 2 days before experiment start&#xD;
&#xD;
        -  Overnight fast&#xD;
&#xD;
        -  Bed rest during experiment as feasible&#xD;
&#xD;
        -  Nasogastric feeding tube&#xD;
&#xD;
        -  Arterial line in radial or ulnar artery&#xD;
&#xD;
      Nutrition, sampling, measurements&#xD;
&#xD;
        -  Experimental nutrition by continuous infusion for 10 hrs&#xD;
&#xD;
        -  Infusion rate corresponding to 25 kcal/kg body weight/day (calculated including&#xD;
           metabolizable tracers/indicators)&#xD;
&#xD;
        -  Arterial blood sampling (à 1 ml) every 5 min in pilot study (may adjust to 10 or 15 min&#xD;
           depending on results of pilot study)&#xD;
&#xD;
        -  Serial abdominal ultrasound for determination of gastric volume (pilot study will&#xD;
           determine how often)&#xD;
&#xD;
      Experimental nutrition&#xD;
&#xD;
        -  Commercially available feeding formula for ICU use (Fresubin® HP Energy or similar) with&#xD;
           added phenylalanine and glucose indicators&#xD;
&#xD;
        -  Intrinsically labeled protein: 13C-L-phenylalanine intrinsically labeled milk protein&#xD;
&#xD;
        -  Nonmetabolisable phenylalanine analogue: D-phenylalanine&#xD;
&#xD;
        -  Free amino acid tracer: stable isotope-labeled phenylalanine tracer (2H5-L-Phe)&#xD;
&#xD;
        -  Non-metabolizable glucose analogue: 3-O-Methyl-d-glucose (3-OMG)&#xD;
&#xD;
        -  Free glucose tracer: isotope labeled D-glucose&#xD;
&#xD;
      Analyses&#xD;
&#xD;
        -  arterial plasma amino acid and glucose tracers as above&#xD;
&#xD;
        -  arterial plasma 3-OMG&#xD;
&#xD;
        -  arterial plasma aminograms&#xD;
&#xD;
        -  arterial plasma glucose, insulin, c peptide&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 1, 2023</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2026</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Glucose and phenylalanine indicators</measure>
    <time_frame>0-10 hours</time_frame>
    <description>Time series of isotopic and non-isotopic indicators of glucose and phenylalanine from enteral nutrition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Gastric volume</measure>
    <time_frame>0-10 hours</time_frame>
    <description>Time series of gastric volume</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma metabolites</measure>
    <time_frame>0-10 hours</time_frame>
    <description>Time series of plasma aminograms, glucose, insulin and c peptide</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Critical Illness</condition>
  <arm_group>
    <arm_group_label>Healthy subjects</arm_group_label>
    <description>Healthy persons ≥ 18 yrs of age</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Critically ill patients</arm_group_label>
    <description>Critically ill patients ≥ 18 yrs of age admitted to the ICU</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous enteral feeding</intervention_name>
    <description>Enteral nutrition by continuous infusion for 10 hrs at a dose corresponding to 25 kcal/kg body weight/day</description>
    <arm_group_label>Critically ill patients</arm_group_label>
    <arm_group_label>Healthy subjects</arm_group_label>
    <other_name>Gastric ultrasound</other_name>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        ICU patients: patients admitted to an intensive care unit at Karolinska University Hospital&#xD;
&#xD;
        Healthy subjects: volunteers from Stockholm metropolitan region&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria (ICU patients):&#xD;
&#xD;
        - stable enteral nutrition of &gt;80% of measured or calculated energy expenditure by&#xD;
        nasogastric feeding tube or gastrostomy&#xD;
&#xD;
        Exclusion Criteria (ICU patients):&#xD;
&#xD;
          -  enteral nutrition by postpyloric route such as jejunostomy or postpyloric tube&#xD;
&#xD;
          -  remaining ICU stay expected &lt; 12 hrs&#xD;
&#xD;
          -  ongoing bleeding that requires surgery/intervention or transfusion of &gt; 2 units red&#xD;
             cells/24 hrs&#xD;
&#xD;
          -  inability to use feeding tube or arterial line&#xD;
&#xD;
        Inclusion Criteria (healthy subjects):&#xD;
&#xD;
        - healthy volunteer&#xD;
&#xD;
        Exclusion Criteria (healthy subjects)&#xD;
&#xD;
        - any condition or medication affecting nutrition or metabolism&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Felix Liebau, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Karolinska University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Felix Liebau, MD PhD</last_name>
    <email>felix.liebau@regionstockholm.se</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Olav Rooyackers, Prof Phd</last_name>
    <phone>+46702069227</phone>
    <phone_ext>+46702069227</phone_ext>
    <email>olav.rooyackers@ki.se</email>
  </overall_contact_backup>
  <reference>
    <citation>Liebau F, Kiraly E, Olsson D, Wernerman J, Rooyackers O. Uptake of dietary amino acids into arterial blood during continuous enteral feeding in critically ill patients and healthy subjects. Clin Nutr. 2021 Mar;40(3):912-918. doi: 10.1016/j.clnu.2020.06.018. Epub 2020 Jun 30.</citation>
    <PMID>32709553</PMID>
  </reference>
  <verification_date>November 2022</verification_date>
  <study_first_submitted>November 17, 2022</study_first_submitted>
  <study_first_submitted_qc>November 17, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 29, 2022</study_first_posted>
  <last_update_submitted>November 29, 2022</last_update_submitted>
  <last_update_submitted_qc>November 29, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">December 2, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Region Stockholm</investigator_affiliation>
    <investigator_full_name>Felix Liebau</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Continuous enteral feeding</keyword>
  <keyword>Gastric volume</keyword>
  <keyword>Intestinal absorption</keyword>
  <keyword>Enteral nutrition</keyword>
  <keyword>Nutritional support</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

